Cracking the Code
New Diagnostic Tool Developed at Dana-Farber Revolutionizes Acute Leukemia Diagnosis
Dana-Farber Treats First Patient with Approved Gene Therapy for Beta Thalassemia
Clinical Trials and Research for Mantle Cell Lymphoma
New Research Sheds Light on Why Tamoxifen May Lead to Higher Risk of Uterine Cancer
Dana-Farber Researchers Find Less Treatment May be More in Mantle Cell Lymphoma
Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark
New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science
Dana-Farber Cancer Institute Unveils Groundbreaking Blood Test for Multiple Myeloma
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs Launch Precision Genomics Initiative for Pediatric Cancer
When Science Moves Mountains
Dana-Farber Research Shows Promise for Targeted Therapies for Pediatric Gliomas
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation’s Best for 2025-2026
Study Paves Path to Improved Diagnosis, Treatment of NUT Carcinoma
Global Rise in Many Early-Onset GI Cancers Detailed in Two Dana-Farber Reviews, With Colorectal Cancer Leading the Trend
Showing 16 - 30 of 1043 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...70 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
